Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. - Wikidata - wikimedia - TriplyDB

Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.

Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.

http://www.wikidata.org/entity/Q37844532

about

Transcutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia in adults Anticonvulsants for fibromyalgia Cognitive behavioural therapies for fibromyalgia Cognitive behavioural therapies for fibromyalgia syndrome Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects Fibromyalgia and disability adjudication: no simple solutions to a complex problem Research to encourage exercise for fibromyalgia (REEF): use of motivational interviewing, outcomes from a randomized-controlled trial Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.The German fibromyalgia consumer reports - a cross-sectional survey.The association of sleep difficulties with health-related quality of life among patients with fibromyalgia Stress and resilience in functional somatic syndromes--a structural equation modeling approach A patient and physician survey of fibromyalgia across Latin America and Europe.Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States.Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study Psychological therapies for the management of chronic pain.Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden.Problems and Solutions for Patients with Fibromyalgia: Building New Helping Relationships.Acupuncture for fibromyalgia in primary care: a randomised controlled trial.Work ability in fibromyalgia: an update in the 21st century.Socioeconomic value of intervention for chronic pain.An open-label long-term phase III extension trial to evaluate the safety and efficacy of pregabalin in Japanese patients with fibromyalgia.The costs associated with sleep symptoms among patients with fibromyalgia.Factors associated with the development of chronic pain after surgery for breast cancer: a prospective cohort from a tertiary center in the United States.Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample.Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults.Is there evidence for any truly effective therapy in fibromyalgia?

P2860

Q24185947-01F8E802-30C8-4169-9987-5ABB2B5DF284 Q24197464-92176AF4-4804-4BEC-9080-CEEB3817FE40 Q24198161-639F94A0-537B-4AA3-A280-E019CB4B474A Q24200637-7B708798-C20E-49E3-8D7E-89294404E2FD Q24201799-9021743E-58A4-4EDA-9725-F2CCAAC369E0 Q26764876-674A3068-E637-4C2F-BC08-9E3658A4F787 Q26801572-F2194B00-6D6E-44A4-955C-2679D6B01FF1 Q28649435-3AF35856-9BF8-485F-AAFC-99F9B3DCED29 Q30531831-6FD2D492-F7D9-49CA-BD71-CFD60DEA1A91 Q34160641-B89F0D24-6C98-468C-AE4E-367F99AF70BA Q34263924-32F9F6C3-A330-4A0F-8550-AA7862EBF036 Q34274619-40C67113-2C32-4E00-83E2-775BC595D0D2 Q34448416-4A944D81-C4F5-409B-881C-42A3F5E2A33B Q34512735-F00C7F54-8839-46FF-858F-A2E4910B61BA Q34773454-440E230B-F433-415D-9B2C-5CBBE32C77CD Q36797580-2FF8A87E-D18B-4C98-B7D9-12E94A2CC267 Q36813454-2063EEF2-11F2-4B36-AD82-95497D36608F Q37702263-C45B3E30-C19D-4F16-9370-EE9B36CE8CA6 Q38185990-C1396112-6B8E-4261-9230-572102F08487 Q38632377-96720D63-B9BB-4F1C-8869-A1C27D1C1305 Q39176636-EEF7A694-0BC6-461F-8EBA-24788916BB2E Q39278819-79F202ED-6245-4191-B3B5-746972A28989 Q39899117-EB526C38-F3EE-4FFD-BC4E-863E397BE3EF Q42679169-89E78542-BF05-4D8B-886F-8CEF7398A14E Q44173534-4973E67F-B3AF-4AFF-B3FF-DF2B88A2D123 Q44663629-B5AD7E82-3C6B-4D94-9F41-1C9530C7BEAE Q47611182-BBF1C39F-1E1F-44C5-99BD-E06AB30C4CD4 Q47662908-C7B6D96B-584E-4894-A234-B91F26EAB70B Q54711248-45D1E04B-A5E9-4507-9288-FED23E5B192A

P2860

Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.

http://www.wikidata.org/entity/Q37844532

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@en

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@nl

type

label

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@en

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@nl

prefLabel

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@en

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@nl

P1433

Q37844532-1370A206-7C19-4BEF-B340-12295A91DF02

P1476

Q37844532-0EED89E0-3B83-4FD9-8754-76548611A45D

P2093

Q37844532-10388373-AB1C-4D58-97C6-1EB538A9343C

Q37844532-3CB77608-C8A2-4286-8802-E82524C2DBAC

Q37844532-40C4C56C-1104-444C-8EA0-72EB2453CD47

Q37844532-487D4B24-687F-46C0-9867-1C195AD9690A

Q37844532-50B73B72-CEC5-4A40-BCBE-709253587EF7

Q37844532-D2B24C02-2988-4F40-82F4-8A951C7EC221

Q37844532-EBB1C12A-72BC-4DA6-8194-20101BAEE6F0

P2860

Q37844532-020307E4-EA6B-4D77-875B-00C16F3A1E51

Q37844532-26FA731A-F31F-42A8-81E7-2E91B649411F

Q37844532-313177C9-B633-42F6-A3A2-11A0F8865098

Q37844532-42D6CAF2-5B83-4B11-845E-83708327C910

Q37844532-4D878007-61D1-448B-8157-6268066C4EEF

Q37844532-7278B0BC-C35F-429D-BF8C-D84FD36F07BC

Q37844532-8D8C3941-BE02-4A5F-881A-A84F74068AD8

Q37844532-AAEB38EC-9EE3-40D3-AC6B-884821D7ABB0

Q37844532-C6C39184-9320-4E2E-9586-BE2ABD4C209C

Q37844532-CD8DBA18-9373-4697-A67B-C7F71D7E5B11

P2888

Q37844532-59799357-A0FF-4CDE-A35C-139AC1A0C5C4

P304

Q37844532-B12B7928-FA79-4F25-BDD9-076DB2312D11

P31

Q37844532-596245FC-7959-4374-9E5C-FBFCBC1D16E4

P356

Q37844532-1F2E2091-E95D-4246-AC91-3B1F29AD9BC1

P433

Q37844532-72B50A70-4518-48B6-8C9C-8E48D598816B

P478

Q37844532-0A7A60D3-06C0-4283-A33C-150FC8A93052

P577

Q37844532-4EE18E47-3443-4EC9-A66E-2FEF59D7E357

P5875

Q37844532-1F379F36-9E17-48DA-9FC6-0EA51F0AFF2A

P6179

Q37844532-0B21CA1E-C0CC-45AB-92EF-E84184FA71C7

P698

Q37844532-3062B23B-EC65-4246-9A9E-8D9ACF3C8C84

P921

Q37844532-E628D910-2183-455D-8A2D-AB9DACD4C3E1

P356

11535250-000000000-00000

P1433

Applied Health Economics and Health Policy

P1476

Impact of fibromyalgia severit ...... uropean cross-sectional study.

@en

P2093

Alesia Sadosky

http://www.w3.org/2001/XMLSchema#string

Andreas Winkelmann

http://www.w3.org/2001/XMLSchema#string

Arthi Chandran

http://www.w3.org/2001/XMLSchema#string

Caroline Schaefer

http://www.w3.org/2001/XMLSchema#string

Gergana Zlateva

http://www.w3.org/2001/XMLSchema#string

Kellie Ryan

http://www.w3.org/2001/XMLSchema#string

Serge Perrot

http://www.w3.org/2001/XMLSchema#string

P2860

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

EULAR evidence-based recommendations for the management of fibromyalgia syndrome.

Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis

Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression.

Pathogenesis of fibromyalgia - a review.

Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study

Societal and patient burden of fibromyalgia syndrome.

Minimal clinically important difference in the fibromyalgia impact questionnaire.

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

P2888

11535250-000000000-00000

P304

125-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11535250-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49846566

http://www.w3.org/2001/XMLSchema#string

P6179

1034260325

http://www.w3.org/2001/XMLSchema#string

P698

21332254

http://www.w3.org/2001/XMLSchema#string

P921